Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-02-26 @ 2:17 AM
Study NCT ID:
NCT04107103
Status:
COMPLETED
Last Update Posted:
2024-06-14
First Post:
2019-09-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma
Sponsor:
AHS Cancer Control Alberta
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Nivo Plus: IIT-0009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |